Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease

Acta Neuropathologica

Volumn 123, Issue 5, 2012, Pages 747-749

  Mori, Fumiaki ^a   Tanji, Kunikazu ^a   Toyoshima, Yasuko ^b   Yoshida, Mari ^c   Kakita, Akiyoshi ^b   Takahashi, Hitoshi ^b   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; OPTINEURIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CADAVER; CELL NUCLEUS INCLUSION BODY; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; KENNEDY DISEASE; LETTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINOCEREBELLAR DEGENERATION; SUBSTANTIA NIGRA; TDP 43 PROTEINOPATHY;

BRAIN DISEASES; FRONTAL LOBE; HUMANS; HUNTINGTON DISEASE; INTRANUCLEAR INCLUSION BODIES; MACHADO-JOSEPH DISEASE; MYOCLONIC EPILEPSIES, PROGRESSIVE; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDES; POSTMORTEM CHANGES; SPINOCEREBELLAR ATAXIAS; TRANSCRIPTION FACTOR TFIIIA;

EID: 84862679022     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0956-x     Document Type: Letter

References (10)

1. De Marco N, Buono M, Troise F, Diez-Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8- dependent manner upon an apoptotic stimulus. J Biol Chem 281:16147-16156 (Pubitemid 43848510)
2. Hortobagyi T, Troakes C, Nishimura AL et al (2011) Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 121:519-527
3. Ito H, Fujita K, Nakamura M et al (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol 121:555-557
4. Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223-226
5. Okita S, Morigaki R, Koizumi H, Kaji R, Nagahiro S, Goto S (2012) Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease. Neuroscience 202:363-370
6. Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, Okamoto K (2011) Optineurin in neurodegenerative diseases. Neuropathology 31:569-574
7. Schwab C, Yu S, McGeer EG, McGeer PL (2012) Optineurin in Huntington's disease intranuclear inclusions. Neurosci Lett 506:149-154
8. Schwab C, Yu S, McGeer PL (2012) Optineurin is colocalized with ubiquitin in Marinesco bodies. Acta Neuropathol 123:289-292
9. Swarup G, Nagabhushana A (2010) Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling. J Biosci 35:501-505
10. Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2:180-191